Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2015 (2015), Article ID 173826, 4 pages
http://dx.doi.org/10.1155/2015/173826
Case Report

Giant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock

1Department of Cardiology, New York University Langone Medical Center, New York, NY 10016, USA
2Department of Radiology, New York University School of Medicine, New York, NY 10016, USA

Received 7 March 2015; Accepted 2 July 2015

Academic Editor: Gianluca Pontone

Copyright © 2015 Rose Tompkins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. T. Cooper Jr., G. J. Berry, and R. Shabetai, “Idiopathic giant-cell myocarditis—natural history and treatment,” The New England Journal of Medicine, vol. 336, no. 26, pp. 1860–1866, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Kandolin, J. Lehtonen, K. Salmenkivi, A. Räisänen-Sokolowski, J. Lommi, and M. Kupari, “Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression,” Circulation: Heart Failure, vol. 6, no. 1, pp. 15–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. T. Cooper Jr. and C. Elamm, “Giant cell myocarditis: diagnosis and treatment,” Herz, vol. 37, no. 6, pp. 632–636, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. T. Cooper, V. Orellana, J. Maleszewski, U. Kuhl, and H. P. Schultheiss, “Long term risk of death, transplantation. and disease recurrence in giant cell myocarditis,” Journal of the American College of Cardiology, vol. 59, no. 13, supplement 1, abstract E1547, 2012. View at Google Scholar
  5. R. A. Davies, J. P. Veinot, S. Smith, C. Struthers, P. Hendry, and R. Masters, “Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome,” Journal of Heart and Lung Transplantation, vol. 21, no. 6, pp. 674–679, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. T. Cooper Jr., G. J. Berry, M. Rizeq, and J. S. Schroeder, “Giant cell myocarditis,” The Journal of Heart and Lung Transplantation, vol. 14, no. 2, pp. 394–401, 1995. View at Google Scholar · View at Scopus
  7. M. S. Nieminen, U.-S. Salminen, E. Taskinen, P. Heikkila, and J. Partanen, “Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy,” The Journal of Heart and Lung Transplantation, vol. 13, no. 3, pp. 543–545, 1994. View at Google Scholar · View at Scopus
  8. V. V. Menghini, V. Savcenko, L. J. Olson et al., “Combined immunosuppression for the treatment of idiopathic giant cell myocarditis,” Mayo Clinic Proceedings, vol. 74, no. 12, pp. 1221–1226, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. L. T. Cooper Jr., J. M. Hare, H. D. Tazelaar et al., “Usefulness of immunosuppression for giant cell myocarditis,” American Journal of Cardiology, vol. 102, no. 11, pp. 1535–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus